Therapeutic agents useful for treating pain

Details Therapeutic agents useful for treating pain Therapeutic agents useful for treating pain

2010-05-24

2011-11-15

Morris, Patricia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S268100

Reexamination Certificate

active

08058292

ABSTRACT:
The invention provides a compound of formula (I):(where R1, Q, A and R2are disclosed herein) or a pharmaceutically acceptable salt thereof (a “Pyridine-alkynyl Compound”); pharmaceutical compositions comprising an effective amount of a Pyridine-alkynyl Compound; and methods for treating or preventing a condition such as pain, urinary incontinence, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, a seizure, stroke, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia or depression in an animal comprising administering to an animal in need thereof an effective amount of a Pyridine-alkynyl Compound.

REFERENCES:
patent: 3536809 (1970-10-01), Applezweig
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 5039680 (1991-08-01), Imperato et al.
patent: 5059595 (1991-10-01), Le Grazie
patent: 5073543 (1991-12-01), Marshall et al.
patent: 5075341 (1991-12-01), Mendelson et al.
patent: 5120548 (1992-06-01), McClelland et al.
patent: 5198459 (1993-03-01), Imperato et al.
patent: 5232934 (1993-08-01), Downs
patent: 5294624 (1994-03-01), Fuse et al.
patent: 5354556 (1994-10-01), Sparks et al.
patent: 5556837 (1996-09-01), Nestler et al.
patent: 5556838 (1996-09-01), Mayer et al.
patent: 5574052 (1996-11-01), Rose et al.
patent: 5591767 (1997-01-01), Mohr et al.
patent: 5639476 (1997-06-01), Oshlack et al.
patent: 5674533 (1997-10-01), Santus et al.
patent: 5698155 (1997-12-01), Grosswald et al.
patent: 5733566 (1998-03-01), Lewis
patent: 5762925 (1998-06-01), Sagen
patent: 6109269 (2000-08-01), Rise et al.
patent: 6136839 (2000-10-01), Isakson et al.
patent: 6156908 (2000-12-01), Drauz et al.
patent: 6204284 (2001-03-01), Beer et al.
patent: 6248756 (2001-06-01), Anthony et al.
patent: 6492541 (2002-12-01), Drauz et al.
patent: 6656957 (2003-12-01), Allgeier et al.
patent: 2004/0044003 (2004-03-01), Kyle et al.
patent: 2004/0053914 (2004-03-01), Gharagozloo et al.
patent: 2004/0102450 (2004-05-01), Ewing et al.
patent: 2004/0106625 (2004-06-01), Kyle et al.
patent: 2004/0127501 (2004-07-01), Chen et al.
patent: 2004/0259931 (2004-12-01), Goodfellow et al.
patent: 04777409.6-2101 (2007-04-01), None
patent: WO 92-02502 (1992-02-01), None
patent: WO 98-20867 (1998-05-01), None
patent: WO 99-37304 (1999-07-01), None
patent: WO 00-47553 (2000-08-01), None
patent: WO 01-17992 (2001-03-01), None
patent: WO 01-96331 (2001-12-01), None
Berkow et al., “Urinary Incontinence,”The Merck Manual of Medical Information, pp. 631-634 (1997).
Masu et al., “Sequence and expression of a metabotropic glutamate receptor”Nature349:760-765 (1991).
Miller et al., “Growth factor upregulation of a phosphoinositide-coupled metabotropic glutamate receptor in cortical astrocytes,”J. Neurosci.15(9):6103-6109 (1995).
Berkow et al., “Seizure Disorders,”The Merck Manual of Medical Information, pp. 345-350 (1997).
Berkow et al., “Stroke,”The Merck Manual of Medical Information, pp. 352-355 (1997).
Buchwald et al., “Long-term, continuous intravenous heparin administration by an implantable infusion pump in ambulatory patients with recurrent venous thrombosis,”Surgery88:507 (1980).
Chiamulera et al., “Reinforcing and Locomotor Stimulant Effects of Cocaine are Absent in mGluR5 Null Mutant Rice,”Nature Neurosci.4(9):873-874 (2001).
Wong et al., “Metabotropic Glutamate Receptors and Epileptogenesis,”Epilepsy Currents2(3):81-85 (2002).
Cooke, “Glycopyrrolate in Bladder Dysfunction,”SA Medical J.63:3 (1983).
D'Amour et al., “A Method for Determining Loss of Pain Sensation,”J. Pharmacol. Exp. Ther.72:74-79 (1941).
Di Marzo et al., “Endovanilloid Signaling in Pain,”Current Opinion in Neurobiology12:372-379 (2002).
Dogrul et al., “Peripheral and Spinal Antihyperalgesic Activity of SIB-1757, A Metabotropic Glutamate Receptor (mGluR5) Antagonist, in Experimental Neuropathic Pain in Rats,”Neurosci. Lett.292(2):115-118 (2000).
During et al., “Controlled Release of Dopamine from a Polymeric Brain Implant: In Vivo Characterization,”Ann. Neurol.25:351 (1989).
Foley, “Pain”Cecil Textbook of Medicine, pp. 100-107 (1996).
Fundytus et al, “Antisense Oligonucleotide Knockdown of mGluR1Alleviates Hyperalgesia and Allodynia Associated with Chronic Inflammation,”Pharmacol., Biochem.&Behavior73:401-410 (2002).
Fundytus et al., “In vivo Antinociceptive Activity of Anti-Rat mGluR1and mGluR5Antibodies in Rats,”NeuroReport9:731-735 (1998).
Fundytus et al., “Knockdown of Spinal Metabotropic Glutamate Receptor 1 (mGluR1) Alleviates Pain Restores Opioid Efficacy after Nerve Injury in Rats,”Brit. J. Pharmacol.132:354-367 (2001).
Fundytus et al., “Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamac receptors on morphine dependence,”Brit. J. Pharmacol.113:1215-1220 (1994).
Fundytus, “Glutamate Receptors and Nociception Implications for the Drug-Treatment of Pain,”CNS Drugs15:29-58 (2001).
Genin et al, “Synthesis and Structure—Activity Relationship of the (Alkylamino)piperidine-Containing BHAP Class of Non-Nucleoside Reverse Transcriptase Inhibitors: Effect of 3-Alkylpyridine Ring Substitution,”J Med Chem42:4140-4149 (1999).
Geri et al. “Reactions of Nitrogen Nucleohiles with I-Bromoallenes: Regioselective Synthesis of Propargylamines,”Gazz. Chim. Ital.124:241-248 (1994).
Brunton, “Agents for Control of Gastric Acidity and Treatment of Peptic Ulcers,”Goodman and Gillman's the Pharmaceutical Basis of Therapeutics, pp. 506, 901-915 (J. Hardman and L. Limbird Eds., 9thed. (1996).
Goodson, inMedical Applications of Controlled Release, vol. 2, pp. 115-138 (1984).
Grupp et al., “Protection against Hypoxia-reoxygenation in the Absence of Poly (ADP-ribose) Synthetase in Isolated Working Hearts,”J. Mol. Cell Cardiol.31:297-303 (1999).
Hanson,Analgesic, Antipyretic and Anti-Inflammatory Drugs in Remington: The Science and Practice of Pharmacy vol. II1196-1221 (A.R. Gennaro ed. 19th ed. 1995).
Hargreaves et al., “A New and Sensitive Method for Measuring Thermal Nociception in Cutaneous Hyperalgesia,”Pain32(1):77-88 (1988).
Hay et al. “Palladium-Catalyzed Hydroarylation of Propiolamides. A Regio-and Stereocontrolled Method for Preparing 3,3-Diarylacrylamides,”J. Org. Chem.63:5050-5058 (1998).
Herzog et al., “Urinary Incontinence: Medical and Psychosocial Aspects,”Annu. Rev. Gerontol. Geriatr.9:74-119 (1989).
Howard et al. “Intracerebral drug delivery in rats with lesion-induced memory deficits,”J. Neurosurg.71:105 (1989).
Insel, “Analgesic-Antipyretic and Anti-inflammatory Agents and Drugs Employed in the Treatment of Gout,” inGoodman&Gilman's The Phamacological Basis of Therapeutics617-57 (Perry B. Molinhoff and Raymond W. Ruddon eds., 9thed 1996).
Jhamandas et al. “Spinal Amino Acid Release and Precipitated Withdrawal in Rats Chronically Infused with Spinal Morphine,”J. Neurosci.16:2758-2766 (1996).
Kim, “An Experimental Model for Peripheral Neuropathy Produced by Segmental Spinal Nerve Ligation in the Rat,”Pain50(3):355-363 (1992).
Weber et al. “Enantiopure 4- and 5-Aminopiperidin-2-ones: Regiocontrolled Synthesis and Conformational Characterization as Bioactive B-Turn Mimetics,”J. Org. Chem.65:7406-7416 (2000).
Langer, “New Methods of Drug Delivery,”Science249:1527-1533 (1990).
Levin et al., “Direct Measurement of the Anticholinergic Activity of a Series of Pharmacological Compounds on the Canine and Rabbit Urinary Bladder,”J. Urology,1

Affiliated with

Also associated with

Rating

Therapeutic agents useful for treating pain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic agents useful for treating pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agents useful for treating pain will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4309882